Praxis Launches Recruitment Campaign for Research Study for a Vaccine to Prevent Cancer Causing Virus

Brentwood, TN -- Feb. 22, 2006 -- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a major pharmaceutical company for a national vaccine research study. The study explores an investigational vaccine for a significant female health issue and is being conducted in more than 5,000 healthy women worldwide, with 900 in the U.S.

Praxis is providing a variety of volunteer recruitment services for the clinical trial, including development of an informational website, public relations, patient education materials, direct marketing and centralized recruitment center management via PraxisDirect.^®

“This study is one of several we are currently involved with in the female health area, and further expands our experience in the area of biologics.” said David Fox, president and CEO of Praxis. “Our expertise in this field and our strategic approach will greatly benefit the recruitment results for the study.”

The recruitment period will last six months for the 36-month, Phase III study, which focuses on a condition that affects 20 million people nationwide. The study is being conducted in 43 research sites.

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Releases